121 related articles for article (PubMed ID: 20485753)
1. One-pot double intramolecular homolytic aromatic substitution routes to dialicyclic ring fused imidazobenzimidazolequinones and preliminary analysis of anticancer activity.
Fagan V; Bonham S; Carty MP; Aldabbagh F
Org Biomol Chem; 2010 Jul; 8(14):3149-56. PubMed ID: 20485753
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and toxicity towards normal and cancer cell lines of benzimidazolequinones containing fused aromatic rings and 2-aromatic ring substituents.
Moriarty E; Carr M; Bonham S; Carty MP; Aldabbagh F
Eur J Med Chem; 2010 Sep; 45(9):3762-9. PubMed ID: 20605274
[TBL] [Abstract][Full Text] [Related]
3. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
Refaat HM
Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
6. Synthesis by radical cyclization and cytotoxicity of highly potent bioreductive alicyclic ring fused [1,2-a]benzimidazolequinones.
Lynch M; Hehir S; Kavanagh P; Leech D; O'Shaughnessy J; Carty MP; Aldabbagh F
Chemistry; 2007; 13(11):3218-26. PubMed ID: 17200920
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents.
Gellis A; Kovacic H; Boufatah N; Vanelle P
Eur J Med Chem; 2008 Sep; 43(9):1858-64. PubMed ID: 18222567
[TBL] [Abstract][Full Text] [Related]
8. Microwave supported synthesis of some novel 1,3-diarylpyrazino[1,2-a]benzimidazole derivatives and investigation of their anticancer activities.
Demirayak S; Kayagil I; Yurttas L
Eur J Med Chem; 2011 Jan; 46(1):411-6. PubMed ID: 21122952
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazole derivatives related to 2,3-acrylonitriles, benzimidazo[1,2-a]quinolines and fluorenes: synthesis, antitumor evaluation in vitro and crystal structure determination.
Hranjec M; Pavlović G; Marjanović M; Kralj M; Karminski-Zamola G
Eur J Med Chem; 2010 Jun; 45(6):2405-17. PubMed ID: 20207049
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.
Stýskala J; Stýskalová L; Slouka J; Hajdúch M
Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255
[TBL] [Abstract][Full Text] [Related]
13. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of antitumor thiazolo[3,4-a]benzimidazole derivatives.
Chimirri A; Grasso S; Montforte AM; Montforte P; Zappalà M; Carotti A
Farmaco; 1994 May; 49(5):337-44. PubMed ID: 8080616
[TBL] [Abstract][Full Text] [Related]
15. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
16. Pyrazoline bearing benzimidazoles: search for anticancer agent.
Shaharyar M; Abdullah MM; Bakht MA; Majeed J
Eur J Med Chem; 2010 Jan; 45(1):114-9. PubMed ID: 19883957
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle disruption and apoptotic activity of 3-aminothiazolo[3,2-a]benzimidazole-2-carbonitrile and its homologues.
Sarhan AA; Al-Dhfyan A; Al-Mozaini MA; Adra CN; Aboul-Fadl T
Eur J Med Chem; 2010 Jun; 45(6):2689-94. PubMed ID: 20226574
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.
Thimmegowda NR; Nanjunda Swamy S; Kumar CS; Kumar YC; Chandrappa S; Yip GW; Rangappa KS
Bioorg Med Chem Lett; 2008 Jan; 18(1):432-5. PubMed ID: 17981032
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]